HHidalgo

TL2 Member · Bremen, DE

UK-based. Mostly the access and pricing categories.

Joined 26 December 2024 · last posted 17d · groups: regional-uk

71 posts, newest first. Showing up to 150.

[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #72 · Access › International · 11 Jul 2026 · 3 likes On post #70 — agreed on the reasoning, with one qualification. Where a jurisdiction has published guidance for clinicians, that document usually answers the practical…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #34 · Compounds › Secretagogues & GH axis · 11 Jul 2026 · 18 likes A purity figure without a method for a short peptide is nearly uninterpretable, because short peptides can be run on gradients that resolve almost nothing and still…
What to include when your question involves a laboratory result Replied, post #11 · Start Here › How to Ask · 10 Jul 2026 · 5 likes Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago" and "recently" are the two least useful words in a question of this…
What is genuinely unknown about long-term amylin agonism Replied, post #7 · Compounds › Cagrilintide & amylin analogues · 6 Jul 2026 · 1 like Narrowing post #4, because the general version has more than one answer. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct…
Personal or family history of medullary thyroid carcinoma Replied, post #6 · Safety › Contraindications · 22 Jun 2026 · 12 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either.
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #28 · Documentation › Doc review · 15 Jun 2026 · 14 likes The arithmetic in post #25 is right; the assumption feeding it is the part to check. What I can speak to on draft on reconstitution arithmetic is narrow, so I will keep…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #94 · Practice › Reconstitution · 7 Jun 2026 · 0 likes If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a lower concentration rather than a more careful hand.
Coming back to: Time to steady state after a dose increase Replied, post #69 · Pharmacology › Pharmacokinetics · 5 Jun 2026 · 5 likes On post #66 — agreed on the reasoning, with one qualification. Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these…
Comparing prices across jurisdictions without misleading yourself Replied, post #37 · Access › Pricing · 4 Jun 2026 · 11 likes This is the sort of exchange that makes the archive worth searching.
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #80 · Evidence › Journal club · 2 Jun 2026 · 12 likes Where the orforglipron phase 2 reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Interim analyses and stopping rules Replied, post #25 · Evidence › Trials · 1 Jun 2026 · 0 likes Distinguishing three things in the interim analyses and stopping rules discussion that keep getting used interchangeably: the observation, the proposed mechanism, and…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #66 · Compounds › Semaglutide · 29 May 2026 · 5 likes Useful. I had the fact and not the reason, which turns out to be the important half.
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #132 · Compounds › Tirzepatide · 20 May 2026 · 10 likes On 2.5 mg starting dose I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #15 · Sourcing › Independent verification · 18 May 2026 · 25 likes Post #11 put the caveat in the right place and I want to underline it. The arithmetic on Janoshik is the easy part and it is where the errors are, which is an…
A checklist for reading a certificate in under two minutes Replied, post #18 · Analytics › COA interpretation · 10 May 2026 · 0 likes I had written a reply contradicting post #15 and deleted it. Here is what survived. A chromatogram supplied as a small image is legible for peak shape and not for…
What to include when your question involves a laboratory result — a second dataset Replied, post #2 · marked as the solution · Start Here › How to Ask · 4 May 2026 · 8 likes The opening post is the version of this I will quote in future. One addition. If the answer you got does not fit your case, say which part does not fit rather than…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #43 · Analytics › Mass spectrometry · 31 Mar 2026 · 0 likes I changed my mind about Charge states after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #135 · Practice › Interactions · 18 Mar 2026 · 33 likes The arithmetic in post #134 is right; the assumption feeding it is the part to check. A pharmacist can answer most questions in this subcategory in a few minutes with…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #57 · Practice › Side effects · 16 Mar 2026 · 30 likes Post #56 is right about the mechanism and I think understates the practical bit. My position on Dizziness on standing is current rather than settled. I have revised it…
Pharmacy supply in the UK and the questions you will be asked Replied, post #75 · Regional › UK & Ireland · 13 Mar 2026 · 1 like Post #74 describes the usual case. This is about the unusual one. Anyone quoting an eligibility threshold should say which document it comes from. The thresholds have…
The lowest dose that does anything: is that a real question? Replied, post #84 · Practice › Dosing & titration · 6 Mar 2026 · 6 likes Where I part company with post #80, and it is a narrow parting. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…
Constipation management, with a dietitian's contribution Replied, post #35 · Practice › Side effects · 1 Mar 2026 · 0 likes I had written a reply contradicting post #33 and deleted it. Here is what survived. The documentation on constipation management is better than this thread and I say…
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #50 · Practice › Storage & stability · 26 Feb 2026 · 5 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. The variance…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #48 · Evidence › Study critique · 12 Feb 2026 · 8 likes Thank you for taking the time. That was more work than a reply usually is.
[2026 update] What a purity-only report leaves out Replied, post #23 · Sourcing › Independent verification · 12 Feb 2026 · 8 likes Where the purity-only discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with…
Specification in the result column: why that is a meaningful error Replied, post #121 · Analytics › COA interpretation · 12 Feb 2026 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
Coming back to: Reading a supplier's product description as a marketing document Replied, post #20 · Compounds › Other compounds · 10 Feb 2026 · 29 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #114 · Clinical › Special populations · 27 Jan 2026 · 17 likes The arithmetic in post #113 is right; the assumption feeding it is the part to check. Medullary thyroid carcinoma history: an absolute contraindication because of the…
Reconstitution volumes that produce round numbers, tabulated Replied, post #30 · Practice › Reconstitution · 22 Jan 2026 · 18 likes Worked example, since the arithmetic is the whole question. Five milligrams into one millilitre is 5 mg/mL. A 0.25 mg dose is 0.05 mL, which is five units on a U-100…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #11 · Research Methods › Statistics · 12 Jan 2026 · 9 likes Answering the question post #7 raises rather than the one it answers. The version of Measurement error in home scales that circulates here is a simplification of a…
Vomiting: when it is expected and when it is a reason to stop Replied, post #104 · Practice › Side effects · 30 Dec 2025 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #10 · Pharmacology › Receptor biology · 12 Dec 2025 · 1 like Everything in post #7 holds. The case it does not cover is the one I have. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion),…
Can a home kit substitute for a laboratory report? A careful no Replied, post #76 · Analytics › Home & field testing · 11 Dec 2025 · 32 likes Where home testing is genuinely valuable is as a screen before spending on independent analysis, not as a substitute for it.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #60 · Compounds › Tirzepatide · 9 Dec 2025 · 1 like Adding the measurement that post #59 says would settle it. The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual.…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #92 · Compounds › Other compounds · 26 Nov 2025 · 0 likes Picking up post #91: that is the part I would want checked first. For any compound without a widely available reference standard, retention-time comparisons across…
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #52 · Practice › Reconstitution · 25 Nov 2025 · 20 likes A 0.3 mL barrel has more space between graduations than a 1 mL barrel for the same volume, which is the entire practical argument for the smaller syringe. Resolution,…
Comparing my trajectory with the trial curves, carefully Replied, post #70 · Outcomes › Progress reports · 2 Nov 2025 · 0 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions.
The anatomy of a question that gets answered within an hour — the long version Replied, post #44 · Start Here › How to Ask · 31 Oct 2025 · 0 likes Picking up post #42: that is the part I would want checked first. The specific question in the title is more useful than you might think. A title like "a question I…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #55 · Lounge › Off topic · 24 Sep 2025 · 0 likes Unserious but true: I can now identify a certificate template at a glance and I have no professional use for that skill whatsoever. I would want to see it done twice…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #134 · Data & Tools › Datasets · 11 Sep 2025 · 0 likes How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset. The…
Pinch or no pinch, and how needle length changes the answer Replied, post #48 · Practice › Administration · 5 Sep 2025 · 0 likes Pinch would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #20 · Analytics › Method validation · 29 Aug 2025 · 27 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one. Correct me on the…
Micronutrient status when intake falls substantially Replied, post #26 · Clinical › Bloodwork · 22 Aug 2025 · 32 likes On micronutrient status: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #29 · Evidence › Journal club · 13 Aug 2025 · 29 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping. It…
What this community means by "a source", in practical terms Replied, post #46 · Start Here › Welcome · 25 Jul 2025 · 8 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
Repeatability versus intermediate precision Replied, post #67 · Analytics › Method validation · 26 Jun 2025 · 26 likes Post #63 describes the usual case. This is about the unusual one. System suitability is the ongoing evidence that a validated method is still performing. Validation is…
Sodium, potassium and magnesium when intake drops Replied, post #16 · Nutrition & Training › Hydration & electrolytes · 14 Jun 2025 · 9 likes Narrowing post #14, because the general version has more than one answer. Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals (sodium,…
What this community means by "a source", in practical terms Replied, post #5 · Start Here › Welcome · 13 Jun 2025 · 0 likes Muting is under-used here. A category you mute stops appearing in Latest for you, and you can unmute it in a second. Most long-term members read four or five categories…
Coming back to: Getting a referral rather than a refusal Replied, post #52 · Clinical › Prescriber conversations · 10 Jun 2025 · 0 likes Taking post #49 at face value and following it one step further. I have three months of notes on Getting a referral and the honest summary is that the trend is real and…
Revisiting: German, French and Dutch differences, compared Replied, post #31 · Regional › European Union · 9 Jun 2025 · 8 likes Taking German seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #50 · Compounds › Cagrilintide & amylin analogues · 9 Jun 2025 · 27 likes Filing a mild objection to the consensus on CagriSema phase 2 paper. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
DXA precision and the least significant change for lean mass — the long version Replied, post #98 · Outcomes › Body composition · 26 May 2025 · 12 likes Distinguishing three things in the DXA precision discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
A well-designed study with a badly written abstract Replied, post #102 · Evidence › Study critique · 23 May 2025 · 24 likes Post #100 answers the question as asked. The question underneath it is different. The bit of well-designed study that nobody enjoys is that the answer changes depending…
Pregnancy as an absolute contraindication Replied, post #60 · Safety › Contraindications · 19 May 2025 · 4 likes I read post #58 twice before replying, because I had assumed the opposite. Anyone posting a contraindication claim should include the source. Without one it circulates…
Counter-ion content and its effect on measured mass Replied, post #20 · Analytics › Mass spectrometry · 19 Apr 2025 · 5 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
Retatrutide dose escalation in the published trials Replied, post #99 · Compounds › Retatrutide · 7 Apr 2025 · 27 likes Anyone deciding on the basis of what is published should know that what is published is a phase 2 programme and some pharmacokinetics. That is a genuinely early…
Charge states for a 4 kDa peptide, worked through Replied, post #67 · Analytics › Mass spectrometry · 10 Mar 2025 · 22 likes An update on my earlier charge states post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #16 · Compounds › Cagrilintide & amylin analogues · 5 Mar 2025 · 0 likes Adding the measurement that post #13 says would settle it. The honest summary of the evidence base: a coherent mechanism, good phase 2 data in combination, and much…
Consistent declarations and why they matter more than clever ones Replied, post #27 · Sourcing › Logistics · 13 Feb 2025 · 0 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. Adding a source would…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #11 · Compounds › Retatrutide · 2 Feb 2025 · 1 like Whether triple agonism is additive or synergistic is an open question and the published work does not answer it. A phase 2 trial without a dual-agonist comparator arm…
Scheduled maintenance and what will be unavailable Replied, post #30 · Meta › Announcements · 1 Feb 2025 · 17 likes Building on post #28 rather than restating it. The reason scheduled maintenance keeps being re-asked is that the answer is conditional and people quote it without the…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #6 · Evidence › Meta-analyses · 25 Jan 2025 · 2 likes Offering a way to settle Random versus fixed effects rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is…
Recovery when intake is low: what to cut first Replied, post #4 · Nutrition & Training › Resistance training · 8 Jan 2025 · 4 likes Recovery capacity falls with energy availability, so a programme that worked at maintenance may be too much during a large deficit.
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #77 · Compounds › Semaglutide · 3 Jan 2025 · 0 likes Worth separating two things that post #75 runs together. Careful with the language on Semaglutide formulation. "Not detected" and "not present" are different findings…
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #8 · Compounds › Oral incretins · 30 Dec 2024 · 13 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #67 · Compounds › Oral incretins · 27 Dec 2024 · 2 likes Taking the oral product with more water than instructed reduces absorption rather than helping it. That is counter-intuitive and it is one of the few dosing…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #25 · Devices › Cold chain · 22 Dec 2024 · 3 likes Post #23 put the caveat in the right place and I want to underline it. Recording arrival condition on ordinary deliveries is what makes the record useful. A file…
Coming back to: When to suspect the method rather than the sample Replied, post #91 · Analytics › Method validation · 18 Dec 2024 · 31 likes Validation is compound-specific and matrix-specific. A method validated for one peptide is a starting point for another and not a validated method for it. Adding it…
Oxidation and deamidation mass shifts, tabulated Replied, post #16 · Analytics › Mass spectrometry · 6 Dec 2024 · 15 likes The arithmetic in post #13 is right; the assumption feeding it is the part to check. Trifluoroacetate adducts are common in material purified with TFA and are one…
The C-cell question: rodent findings and their human context — what changed since Replied, post #23 · Compounds › Semaglutide · 27 Aug 2024 · 1 like C-cell question has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
Guidelines revision: what changed and why Replied, post #108 · Meta › Announcements · 28 Jul 2024 · 26 likes What I want from this guidelines revision thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.